Indian Pharma sector registers growth of 7.7% in May 2016

The Indian pharmaceutical sector has registered a growth of 7.7 % in May 2016 according to data by AIOCD-AWACS, the market research arm of the All India Organization of Chemists and Druggists (AIOCD).

The ban on fixed-dose combination (FDC) drugs seems to have an impact on the growth of the sector, though the experts feel that the effect will gradually wane off in the times to come. The non-FDC category, however registered a better growth of 8.4% in May 2016.  344 FDCs were banned by the Centre on the basis of findings of an expert panel.

Therapy wise, it was observed that anti-diabetic, neurology/CNS and cardiac segments registered a higher growth than the market by 250-700 bps while the gastrointestinal and anti-infective segments had lower growth figures.